DCF — NORTH COLORADO MEDICAL CENTER
Enterprise Value: $-649.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-649.2M
Enterprise Value
$-202.9M
PV of Cash Flows
$-446.3M
PV of Terminal Value
$-718.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $331.5M | $-41.8M | -13.0% | $-55.8M | $-50.8M |
| Year 2 | $341.5M | $-39.7M | -12.0% | $-54.1M | $-44.7M |
| Year 3 | $351.7M | $-37.3M | -11.0% | $-52.2M | $-39.2M |
| Year 4 | $362.3M | $-36.6M | -10.0% | $-52.0M | $-35.5M |
| Year 5 | $373.1M | $-36.8M | -10.0% | $-52.6M | $-32.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-649.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$321.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13112843507851676
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5